BIOMAT Database Logo BIOMAT Database Logo

Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia. 2020

Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.

Glucocorticoids and asparaginase, used to treat acute lymphoblastic leukemia (ALL), can cause hypertriglyceridemia. We compared triglyceride levels, risk factors, and associated toxicities in two ALL trials at St. Jude Children's Research Hospital with identical glucocorticoid regimens, but different asparaginase formulations. In Total XV (TXV), native Escherichia coli l-asparaginase was front-line therapy versus the pegylated formulation (PEG-asparaginase) in Total XVI (TXVI). Patients enrolled on TXV (n = 498) and TXVI (n = 598) were assigned to low-risk (LR) or standard/high-risk (SHR) treatment arms (ClinicalTrials.gov identifiers: NCT00137111 and NCT00549848). Triglycerides were measured four times and were evaluable in 925 patients (TXV: n = 362; TXVI: n = 563). The genetic contribution was assessed using a triglyceride polygenic risk score (triglyceride-PRS). Osteonecrosis, thrombosis, and pancreatitis were prospectively graded. The largest increase in triglycerides occurred in TXVI SHR patients treated with dexamethasone and PEG-asparaginase (4.5-fold increase; P <1 × 10-15 ). SHR patients treated with PEG-asparaginase (TXVI) had more severe hypertriglyceridemia (>1000 mg/dL) compared to native l-asparaginase (TXV): 10.5% versus 5.5%, respectively (P = .007). At week 7, triglycerides did not increase with dexamethasone treatment alone (LR patients) but did increase with dexamethasone plus asparaginase (SHR patients). The variability in triglycerides explained by the triglyceride-PRS was highest at baseline and declined with therapy. Hypertriglyceridemia was associated with osteonecrosis (P = .0006) and thrombosis (P = .005), but not pancreatitis (P = .4). Triglycerides were affected more by PEG-asparaginase than native l-asparaginase, by asparaginase more than dexamethasone, and by drug effects more than genetics. It is not clear whether triglycerides contribute to thrombosis and osteonecrosis or are biomarkers of the toxicities.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Optimizing asparaginase therapy for acute lymphoblastic leukemia.
March 2013, Current opinion in oncology,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
January 1997, Annals of clinical and laboratory science,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia.
August 2016, Current oncology (Toronto, Ont.),
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
L-asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23 abnormality.
November 2009, Leukemia research,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Acute parotitis during induction therapy including L-asparaginase in acute lymphoblastic leukemia.
February 1994, Annals of hematology,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
L-asparaginase induced acute parotitis during intensification therapy of acute lymphoblastic leukemia.
January 2014, Indian journal of cancer,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Peg-asparaginase for acute lymphoblastic leukemia.
May 2010, Expert opinion on biological therapy,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.
October 2017, Pediatric blood & cancer,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
December 2000, The Medical journal of Malaysia,
Emily R Finch, and Colton A Smith, and Wenjian Yang, and Yiwei Liu, and Nancy M Kornegay, and John C Panetta, and Kristine R Crews, and Alejandro R Molinelli, and Cheng Cheng, and Deqing Pei, and Laura B Ramsey, and Seth E Karol, and Hiroto Inaba, and John T Sandlund, and Monika Metzger, and William E Evans, and Sima Jeha, and Ching-Hon Pui, and Mary V Relling
Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
October 2012, Pediatric blood & cancer,
Copied contents to your clipboard!